Category: Heart Failure
-
-
-
2nd ESC 2024 Congress Coverage: FINEARTS-HF Trial
September 15, 20242nd ESC 2024: FINEARTS-HF Trial
-
-
ACC.24 Congress Coverage: Empagliflozin after Acute Myocardial Infarction
May 5, 2024ACC.24: EMPACT-AMI trial
-
ACC.24 Congress Coverage: Safety and Efficacy of Ninerafaxstat in Patients With Nonobstructive Hypertrophic Cardiomyopathy
April 27, 2024ACC.24: IMPROVE-HCM trial
-
ACC.24 Congress Coverage: Interatrial shunt therapy in advanced heart failure
April 27, 2024ACC.24: RELIEVE-HF trial
-
ACC.24 Congress Coverage: Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy
April 17, 2024ACC.24: ARISE-HF Trial
-
ACC.24 Congress Coverage: Effect of Sodium-Glucose Cotransporter 2 Inhibitors in Adults With Congenital Heart Disease
April 17, 2024ACC.24: SGLT2i in ACHD
-
ACC.24 Congress Coverage: Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes
April 16, 2024ACC.24: Semaglutide in HFpEF and DM
-
Cardiology Online Grand Round: The Art of Optimal Medical Therapy for Heart Failure
April 1, 2024Cardiology Online Grand Round: OMT in HF
-
Save The Date: Cardiology Online Grand Round
March 6, 2024Save The Date: Cardiology Online Grand Round
-
-
-
mpact: Cardiovascular and Non-cardiovascular Prescribing and Mortality After Takotsubo – Comparison With Myocardial Infarction and General Population
February 3, 2024Impact: Mortality After Takotsubo – Comparison With MI and General Population
-
Impact: Validity of a speech analysis app for the prediction of HF worsening
January 16, 2024Impact: Speech analysis to predict HF events, Cordio HearO
-
-
AHA23 Congress Coverage: Impact of Female Sex on Cardiogenic Shock Outcomes: A Cardiogenic Shock Working Group Report
November 20, 2023A23 Congress Coverage: Cardiogenic Shock in Women
-
AHA23 Congress Coverage: Daily Marijuana Use is Associated With Incident Heart Failure: “All of Us” Research Program
November 18, 2023AHA23 Congress Coverage: Daily Marijuana and HF ("All of Us Research Program")
-
AHA23 Congress Coverage: Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure: DAPA-MI trial
November 18, 2023AHA23 Congress Coverage: Dapagliflozin in MI without DM or HF (DAPA MI)
-
Case Discussion 101: ICD implantation in patients with non-ischemic dilated cardiomyopathy
November 1, 2023Case Discussion 100: ICD in non-ischemic dilated CMP
-
Light Rounds Volume 5: 22 Y/O lady with frequent PVCs
October 11, 2023Light Round Volume 5: Approach to a patient with frequent PVCs
-
-
ESC 2023 Congress Coverage: 2023 ESC Guidelines for the management of cardiomyopathies
September 17, 2023ESC 2023: New Cardiomyopathies Guideline
-
ESC 2023 Congress Coverage: 2023 Focused Update of the 2021 HF Guideline
September 9, 2023ESC 2023: HF Guideline Update
-
-
-
-
-
-
-
-
-
-
-
Daily Cardiology Symposium 1402 Day 1 Panel 2
July 25, 2023Acute De Novo Heart Failure and Cardiogenic Shock
-
-
-
-
Light Rounds Volume 3: elderly gentleman with ICMP and LV thrombus
June 6, 2023Light Rounds 3: LV thrombus
-
-
-
Young Cardiologist Award 1402 Introduction video by Dr. Aminian
May 18, 2023YCA 1402 introduction by Dr. Aminian
-
Young Cardiologist Award 1402 Introduction video by Dr. Shishehbor
May 13, 2023YCA 1402 introduction by Dr. Shishehbor
-
Impact: Variation in Renal Function Following Transition to Sacubitril/Valsartan in Patients With Heart Failure
May 6, 2023Impact: Sacubitril/Valsartan and renal function in HF
-
Save the Date: American College of Cardiology 2023 Congress Coverage
May 1, 2023Save the Date: ACC.23 congress coverage
-
Young Cardiologist Award 1402 Introduction video by A. Yahyavi, MD
April 29, 2023YCA 1402 introduction by Dr. Yahyavi
-
-
Daily Cardiology Symposium 1402 Save The Date poster Motion
April 10, 2023DCS 1402 Save The Date Poster Motion
-
-
-
Case Discussion 70: Potassium supplementation in mild to moderate Hypokalemia
January 21, 2023Case Discussion 70: Management of mild to moderate Hypokalemia
-
-
Impact: Association of Sacubitril/Valsartan administration and the severity of functional MR in HFrEF
October 16, 2022Impact: Sacubitril/Valsartan and MR severity in HFrEF
-
Umbrella: Heart Failure, Panel 4, Heart Failure with EF more than 40%
September 13, 2022Umbrella: HF, Heart Failure with EF>40%
-
Umbrella: Heart Failure, Panel 3, Acute Decompensated Heart Failure
September 13, 2022Umbrella: HF, Acute Decompensated HF
-
Umbrella: Heart Failure, Panel 1, Pharmacotherapy in HFrEF
September 13, 2022Umbrella: HF, Pharmacotherapy in HFrEF
-
Care Gaps in Adherence to Heart Failure Guidelines
September 12, 2022Care Gaps in Adherence to Heart Failure Guidelines
-
-
-
-
-
-
-
Save the date: European Society of Cardiology 2022 congress coverage
August 22, 2022Save the date: ESC 2022 congress coverage
-
-
-
-
-
-
-
-
-
-
-
Daily Cardiology Symposium 1401 faculty and executive committee motion
May 14, 2022DCS 1401 faculty and executive committee motion
-
American College of Cardiology (ACC) congress 2022 landmark trials review
May 3, 2022ACC 2022 congress coverage
-
Daily Cardiology Symposium 1401 faculty and executive committee
April 18, 2022DCS 1401 faculty and executive committee
-
-
-
-
Save the date: Cardiometabolic grand round 6
March 2, 2022Save the date: the 6th cardiometabolic grand round
-
HeartCast 5: practical approach to the treatment of HFrEF
February 23, 2022The fifth HeartCast: HFrEF management
-
-
-
HeartCast 4: practical approach to the treatment of HFrEF
February 9, 2022The fourth HeartCast: HFrEF management
-
-
HeartCast 3: practical approach to the treatment of HFrEF
January 11, 2022The third HeartCast: HFrEF management
-
Save the date: A glimpse of DCS 1400 and invitation to DCS 1401
January 7, 2022DCS 1400 review and what’s coming next
-
-
HeartCast 2: practical approach to the treatment of HFrEF
December 29, 2021The second HeartCast: HFrEF management
-
HeartCast 1: practical approach to the treatment of HFrEF
December 15, 2021The first HeartCast: HFrEF management
-
-
-
Late-breaking Science in Cardiovascular disease prevention
November 2, 2021ESC 2021 cardiovascular prevention guideline lectures and discussion
-
Save the date: Cardiorenal Metabolic Crossroads: Case-based Panel Discussion, 4th Session
November 1, 2021The 4th session of Cardiorenal metabolic crossroads program
-
-
Save the date; Cardiorenal Metabolic Crossroads: case-based panel discussion
October 10, 2021The second session of Cardiorenal metabolic crossroads program
-
Save the date; DiaBeat: The Beating Heart of Diabetes
October 9, 20218th Diabetes Masterclass for Cardiologists
-
-
-
Cardio-Watch Podcast: Episode 7, ESC 2021 special
September 20, 2021The seventh episode of Cardio-Watch: ESC 2021
-
-
-
Effect of Neprilysin Inhibition on LV Remodeling in Asymptomatic LV Systolic Dysfunction After MI
August 24, 2021Neprilysin Inhibitors to prevent LV remodeling post MI
-
-
Long-term event-free and overall survival with Dapagliflozin in HFrEF patients
August 21, 2021Impact of Dapagliflozin on the survival of HFrEF patients
-
-
Save the date: Umbrella, Focused cardiology forums
July 27, 2021The first session of Umbrella series
-
-
Cardio-Watch Podcast: Episode 5, cardiometabolic disorders
July 12, 2021The fifth episode of Cardio-Watch: cardiometabolic disorders
-
Testing for Iron deficiency and use of Ferric Carboxymaltose in HF patients
July 5, 2021Diagnosis and management of Iron deficiency in HF patients
-
Cardio-Watch Podcast: Episode 4, Dyslipidemia
June 28, 2021The fourth episode of Cardio-Watch: Dyslipidemia
-
-
-
Left Atrial Appendage Occlusion to prevent Stroke
June 9, 2021Preventing Stroke by surgical LA Appendage Occlusion
-
Save the date; DiaBeat: The Beating Heart of Diabetes
June 8, 20216th Diabetes Masterclass for Cardiologists
-
Save the date: Cardiometabolic Grand Round 4th session
June 1, 2021The fourth session of Cardiometabolic grand round
-
Cardiopoint 12: Two-Drug Combinations as First-Step Antihypertensive treatment
May 30, 2021Initial administration of two-drug combinations in HTN
-
Cardio-Watch podcast: Episode 2, Hypertension
May 29, 2021The second episode of Cardio-Watch: Hypertension
-
Cardio-Watch Podcast: Episode one; COVID-19 and the heart
May 15, 2021The first episode of Cardio-Watch podcast
-
Impact: No-LVT trial
April 13, 2021Comparative study of oral anticoagulation in left ventricular thrombi
-
DiaBeat: The Beating Heart of Diabetes (4th session)
April 12, 20214th Diabetes Masterclass for Cardiologists
-
DiaBeat: The Beating Heart of Diabetes (3rd session)
April 12, 20213rd Diabetes Masterclass for Cardiologists
-
DiaBeat: The Beating Heart of Diabetes (2nd session)
April 11, 20212nd Diabetes Masterclass for Cardiologists
-
DiaBeat: The Beating Heart of Diabetes (1st session)
April 10, 20211st Diabetes Masterclass for Cardiologists
-
Daily Cardiology Symposium 1400. Concise, Precise, Practical
April 10, 2021Case-based review of common cardiovascular practice The digital experience
-
Dual RAAS inhibition in the treatment of systolic heart failure; at a glance Part two: Eplerenone in the guidelines
April 7, 2021Latest guideline recommendations on the use of RAAS inhibitors in heart failure patients
-
Dual RAAS inhibition in the treatment of systolic heart failure; at a glace Part one: Eplerenone in the pipeline
April 6, 2021Latest pieces of evidence regarding the use of RAAS inhibitors in heart failure patients
-
Save the date: Daily Cardiology Symposium 1400
March 11, 2021Case-based review of common cardiovascular practice
-
-
Cardiometabolic Grand Round (3)
February 27, 2021A brief talk on DM medication challenges in patients with CVD
-
An introduction to daily cardiology academy symposium; a digital learning opportunity
February 26, 2021Invitation for attending the symposium by executive directors
-
Save the date; DiaBeat: The Beating Heart of Diabetes
February 23, 20214th Diabetes Masterclass for Cardiologists
-
Guideline Directed Medical Therapy in Patients with HF
February 17, 2021Quick review on place of MRAs in patients with HFrEF
-
Guideline Directed Medical Therapy in Patients with HF
February 7, 2021Quick review on place of Beta-Blockers in patients with HFrEF
-
CardioPoint (10): The growing burden of cardiovascular diseases
February 2, 2021Emphasizing the importance of CVD prevention and management
-
Guideline Directed Medical Therapy in Patients with HF
February 1, 2021Updates on ACEI/ARB place in patients with HFrEF (2021 Guideline)
-
Save the date; DiaBeat: The Beating Heart of Diabetes
January 28, 20213rd Diabetes Masterclass for Cardiologists
-
Introduction: Evolution of DOACs and their place in Guidelines
January 21, 2021A brief report of Guidelines mentioned DOACs place in practice
-
Save the date: To DOAC or Not To DOAC
January 21, 2021Rapid review of oral Anticoagulation practice in different clinical scenarios
-
To DOAC or Not to DOAC
January 21, 2021Rapid review of oral anticoagulation practice in different clinical scenarios
-
Impact: Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomized, open-label trial
January 20, 2021Continue vs Stop of RAS inhibitors in patients with COVID-19
-
Save the date: 1st Daily Cardiology Symposium
January 19, 2021Case-based review of common cardiometabolic practice
-
Complete Session;SGLT2 inhibition: Making waves in the heart failure landscape
January 12, 2021Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology
-
SGLT2 inhibitors in the treatment of HF: the future is bright?
January 12, 2021Cardiologist Perspective on SGLT2 inhibitors
-
SGLT2 inhibition: A snapshot into their evolution
January 12, 2021Endocrinologist Perspective on SGLT2 inhibitors
-
SGLT2 inhibition: Making waves in the heart failure landscape
January 12, 2021Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology
-
Residents’ Island: Abidi CVD Prevention Academy
January 12, 2021Multidisciplinary approach to CVD Prevention
-
Save the date: SGLT2 inhibition: Making waves in the heart failure landscape
December 31, 2020Role of SGLT2 inhibitors in HF patients from two perspectives: Endocrinology & Cardiology
-
Save the date: Cardiometabolic Grand Round (2)
December 27, 2020A brief talk on DM medication challenges in patients with CVD
-
Impact: EMPA-RESPONSE-AHF
December 7, 2020Empagliflozin effects on clinical outcomes in patients with ADHF (EMPA-RESPONSE-AHF)
-
What is new in the 2020 ESC Guideline for the diagnosis and management of Atrial Fibrillation
December 7, 2020Part Four: LSM, bleeding management, pregnancy, POAF, sex related differences
-
Cardiometabolic Grand Round (2)
December 7, 2020A brief talk on DM medication challenges in patients with CVD
-
What is new in the 2020 ESC Guideline for the diagnosis and management of AF
December 3, 2020Part Three: Cardioversion, rhythm control, catheter ablation Long term anti arrhythmic drugs
-
A Polypill For the Prevention of CVD in Intermediate Risk Patients: Results of the International Polycap Study (TIPS-3 Trial)
December 2, 2020A quick review on the findings of TIPS-3 trial from AHA congress 2020
-
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients with T2DM and Moderate Renal Impairment Who Are at Cardiovascular Risk (SCORED)
December 2, 2020The Important findings of SCORED trial from AHA 2020 congress in brief
-
High Dose Vs Standard Dose Influenza Vaccine in Patients with a High-Risk for Cardiovascular Disease (INVESTED)
December 2, 2020A quick review on the findings of INVESTED trial from AHA congress 2020
-
Global Approach to Lowering Adverse Cardiac Outcomes Through Improving Contractility in HF (GALACTIC-HF Trial)
December 2, 2020A quick review on the findings of GALACTIC-HF trial from AHA congress 2020
-
Effects of Evolocumab on Complex Coronary Disease Requiring Revascularization
November 30, 2020Evolocumab in the pipeline
-
Sotagliflozin and Cardiovascular Events in T2DM Post Worsening HF (SOLOIST-WHF)
November 30, 2020Sotagliflozin in T2DM and exacerbated HF
-
Ferric Carboxymaltose for iron deficiency at discharge after acute heart failure (AFFIRM-AHF)
November 26, 2020Iron supplementation in acute heart failure
-
Save the Date: Antithrombotic Therapy to Prevent Cardiovascular Events in Type 2 Diabetes
November 4, 2020Comprehensive talk on DAPT vs Low dose Rivaroxaban in patients with T2DM and CVD
-
What is new in the 2020 ESC Guideline for the diagnosis and management of AF
November 3, 2020Part Two: Prevention of thromboembolic events Patients with AF and an ACS, PCI or CCS
-
Save the date: Cardiometabolic Grand Round
November 1, 2020A brief talk on DM management in patients with CVD
-
-
Monitor eGFR in Patients Treated with Metformin
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Patient factors influencing the selection of glucose-lowering drugs other than SGLT2i and metformin in T2D and CKD
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Glycemic Management for patients with T2DM and CKD
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Monitoring of ACEI/ ARB Treatment in Patients with T2DM and CKD
November 1, 2020KDIGO 2020 Clinical Practice Guideline for DM Management in CKD
-
Save the date: ESC 2020 Congress Coverage What is new on NSTE-ACS Guideline: a panel discussion
October 31, 2020Brief Discussion on the New ESC Guideline on NSTE-ACS
-
Save the date: Comprehensive risk reduction in DM
October 29, 2020Collaborative management of DM: Endocrinologist, Nephrologist and Cardiologist team work
-
How to Implement the Newest Diabetes Therapies in HF Treatment
October 29, 2020New insight from EMPEROR Reduced Trial
-
Save the Date: What we learned from ESC Congress about HTN Management
October 22, 2020A Brief Discussion on HTN Management Pearls of ESC 2020
-
What we learned from ESC Congress about HTN Management
October 22, 2020A Brief Discussion on HTN Management Pearls of ESC 2020
-
At a glance; Place of FDC in CV outcomes
October 7, 2020Single-Pill Combination Therapy and CV Outcomes in HTN
-
What is new in the 2020 ESC Guideline for the diagnosis and management of AF
October 3, 2020Updated changes in AF ESC 2020 compared to previous Guidelines (Part one)
-
ESC 2020 Congress Coverage What is new on NSTE-ACS Guideline: a panel discussion
October 2, 2020Brief Discussion on the New ESC Guideline on NSTE-ACS
-
Diabetes and Cardiovascular Diseases
September 29, 2020On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors
-
The weight of the world: The global challenge of obesity
September 29, 2020On the occasion of World Heart Day 2020 for the management of Cardiovascular risk factors
-
Ground-breaking research from ESC Congress 2020 (21)
September 16, 2020Part Twenty-One: Trial Review, BPLTTC (CANCER)
-
Ground-breaking research from ESC Congress 2020 (19)
September 16, 2020Part Nineteen: Trial Review, EXPLORER-HCM
-
Ground-breaking research from ESC Congress 2020 (15)
September 16, 2020Part Fifteen: Trial Review, PARALLAX
-
Ground-breaking research from ESC Congress 2020 (13)
September 16, 2020Part Thirteen: Trial Review, BAMI
-
Ground-breaking research from ESC Congress 2020 (11)
September 16, 2020Part Eleven: Trial Review, DAPA-CKD
-
Ground-breaking research from ESC Congress 2020 (10)
September 16, 2020Part Ten: Trial Review, DECLARE-TIMI
-
Ground-breaking research from ESC Congress 2020 (9)
September 16, 2020Part Nine: Trial Review, RATE-AF
-
Ground-breaking research from ESC Congress 2020 (4)
September 16, 2020Part Four: Trial Review, BRACE-CORONA
-
Ground-breaking research from ESC Congress 2020 (2)
September 16, 2020Part Two: Trial Review, EMPEROR-REDUCED
-
Save the date: Daily Cardiology Journal Club: 3rd Session – EMPEROR-REDUCED Trial
September 15, 2020Monthly Case-Based Clinical Problem Solving
-
Daily Cardiology Journal Club: 3rd Session – EMPEROR-REDUCED Trial
September 15, 2020Monthly Case-Based Clinical Problem Solving
-
Save the date: Ground-breaking research from ESC Congress 2020
September 10, 2020Brief Review of Main Trials Discussed in ESC Congress 2020
-
Ground-breaking research from ESC Congress 2020
September 10, 2020Brief Review of Main Trials Discussed in ESC Congress 2020
-
Impact: Mavacamten for the treatment of symptomatic HCM
August 31, 2020The findings of EXPLORER HCM trial
-
Impact: cardiovascular and renal outcomes of Empagliflozin in HF
August 31, 2020The findings of EMPEROR-REDUCED trial
-
-
CardioPoint (9): Once vs. twice-daily NOACs and adherence considerations
August 22, 2020A Brief Description on Practical Points in Anticoagulation
-
Case Discussion (29)
August 12, 2020Pharmacotherapy approach to ACE/ARB induced AKI in HFrEF patients
-
A music from the heart
August 8, 2020The S3 sound mixed into a delightful eastern melody by a talented Iranian physician
-
Case Discussion (24)
August 4, 2020Frequent VPB in a lady with HTN and mild LV systolic dysfunction
-
-
-
Save the date: Cardiometabolic Care Network
July 16, 2020Interprofessional Collaboration Practice in Risk Management of ASCVD
-
Cardiometabolic Care Network
July 16, 2020Interprofessional Collaboration Practice in Risk Management of ASCVD
-
-
-
Save the date: Optimizing Heart Failure Care Throughout the Patient Journey
June 30, 2020A Case Based Panel Comprehensive Discussion on HF Pharmacotherapy
-
Optimizing Heart Failure Care Throughout the Patient Journey
June 25, 2020A Case Based Panel Comprehensive Discussion on HF Pharmacotherapy
-
CardioPoint (8): When to consider drug treatment in hypertension?
May 24, 2020A Brief Description on Practical Points in Cardiometabolic Field
-
COVID and Cardiometabolic Challenges
April 10, 2020Multidisciplinary approach to COVID-19 Cardiometabolic Complications
-
Save the date: COVID and Cardiometabolic Challenges
April 3, 2020Multidisciplinary approach to COVID-19 Cardiometabolic Complications
-
At a glance: ACEI and ARB in COVID-19 Era
March 19, 2020The challenge of to use or not to use ACEI/ARBs in patients with COVID-19
-
Case Discussion (4)
March 4, 2020Evidenced based discussion on routine cases of cardiology in clinical practice - Approach to wall motion abnormality in Echocardiography
-
Cardiovascular medication interactions with antiviral agents used for COVID-19
March 3, 2020Quick review of CV medications interactions with medications used for COVID-19
-
Cardiovascular medication interactions with antiviral agents used for COVID-19: Second Update
March 3, 2020Quick review of CV medications interactions with medications used for COVID-19
-
-
CardioPoint (7): Selecting appropriate NOAC
February 28, 2020A Brief Description on Practical Points in Anticoagulation
-
Dapagliflozin in concurrent Atrial Fibrillation and T2DM
February 12, 2020Insights from DECLARE-TIMI 58 Trial
-
Case Discussion (3)
February 4, 2020Evidenced based discussion on routine cases of cardiology in clinical practice - Diagnostic approach and treatment of ASD
-
OACs vs. antiplatelet or placebo for stroke prevention in patients with HF and sinus rhythm
February 3, 2020A meta-analysis of RCTs
-
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in T2DM
January 18, 2020The renal and cardiovascular protective effects of SGLT2 inhibitors
-
Guideline Made Easy
December 7, 2019Practical Guide for Treatment of High Blood Pressure (Part Three)
-
Guideline Made Easy
December 7, 2019Practical Guide for Treatment of High Blood Pressure (Part Two)
-
Guideline Made Easy
December 7, 2019Practical Guide for Treatment of High Blood Pressure (Part One)
-
-
Case Discussion (1)
December 4, 2019Evidenced based discussion on routine cases of cardiology in clinical practice Appropriate OAC choice in AF
-
Dapagliflozin in non-DM Patients with HF and Reduced EF
December 2, 2019The findings of DAPA-HF trial in non-diabetics
-
CardioPoint (6): Treatment Target & Goal for LDL-Cholesterol
November 29, 2019A Brief Description on Practical Points in Cardiometabolic Field
-
Optimal Medical Therapy vs. Revascularization in Chronic Coronary Syndrome
November 29, 2019The findings of ISCHEMIA trial
-
Ischemic Cardiomyopathy to be Revascularized and How?
November 19, 2019Pass the torch: Educational sessions for Interventional Cardiologists, Review of ESC 2019 CCS Guideline
-
How to Select Appropriate Testing?
November 19, 2019Pass the torch: Educational sessions for Interventional Cardiologists, Review of ESC 2019 CCS Guideline
-
Anti-ischemic Medications
November 19, 2019Pass the torch: Educational sessions for Interventional Cardiologists, Review of ESC 2019 CCS Guideline
-
Guideline Made Easy
November 3, 2019Practical Guide for treatment of high blood cholesterol Part Three
-
Risk of Mortality Following Catheter Ablation of AF
November 3, 2019Mortality risk after AF ablation
-
Bedtime hypertension treatment improves cardiovascular risk reduction
October 29, 2019The findings of Hygia Chronotherapy Trial
-
CardioPoint (5): NOACs in CKD
October 23, 2019A Brief Description on Practical Points in Anticoagulation
-
Cardiology Close-Up (7)
October 7, 2019Pharmacologic Therapy for LDL Cholesterol Treatment Goal and Pharmacologic Therapy for LDL Cholesterol
-
Guideline Made Easy
October 3, 2019Practical Guide for treatment of high blood cholesterol Part Two
-
CardioPoint (4): Fixed-Dose Combination Pills in the Management of Hypertension
September 20, 2019A Brief Description on Practical Points in Cardiometabolic Field
-
CardioPoint (3): NOACs in Elderly
August 19, 2019A Brief Description on Practical Points in Anticoagulation
-
-
-
CardioPoint (2) – NOAC Monitoring, Do NOACs Need Monitoring?
June 19, 2019A Brief Description on Practical Points in Anticoagulation
-
Case Discussion (26)
September 4, 2017The optimal duration of beta-blocker therapy after myocardial infarction
-
